Centre for Reproductive Medicine, Shanghai 10th People Hospital of Tongji University, Shanghai, China.
Department of Basic Medical Science, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
Front Endocrinol (Lausanne). 2022 Aug 3;13:906570. doi: 10.3389/fendo.2022.906570. eCollection 2022.
We evaluated metabolic profiles between cumulus cells (CCs) and mural granulosa cells (MGCs) derived from women with endometriosis to identify their correlations with oocyte quality. CCs and MGCs were collected from women with and without endometriosis undergoing fertilization/intracytoplasmic sperm injection treatment. The metabolomics of CCs and MGCs were measured by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) followed by a quantitative polymerase chain reaction to further confirm the genes involved in the metabolic results. LC-MS/MS analysis revealed differences in 24 metabolites of CCs and 71 metabolites of MGCs between groups. Among them, five metabolites were upregulated and 19 metabolites were downregulated in CCs with endometriosis, whereas three metabolites were upregulated and 68 metabolites were downregulated in MGCs with endometriosis. Metabolites related to sphingolipid metabolism, which included palmitic acid (PA) and docosahexaenoic acid, increased significantly only in CCs with endometriosis, whereas sphingosine and PA were significantly downregulated in MGCs with endometriosis compared with CCs and MGCs without endometriosis. Gene expression involved in ceramide synthesis (CERS1, SPTL1, and SMPD1) and autophagy (BECN1, LAMP, and PC3) were significantly higher in CCs with endometriosis according to FASN, BECN1, and LAMP protein expressions. However, gene expression involved in ceramide synthesis (SPHK1, ASAH1, and SGPP1) and autophagy (BECN1, LAMP, and PC3) were significantly lower in MGCs with endometriosis, whereas CERS1 and UGCG expression increased. There are differences in sphingolipid metabolites in CCs and MGCs with endometriosis compared with women without endometriosis. These differences seem to be involved in the regulation of autophagic cell death in preovulatory follicles.
我们评估了来自子宫内膜异位症患者的卵丘细胞 (CCs) 和壁颗粒细胞 (MGCs) 的代谢谱,以确定它们与卵母细胞质量的相关性。从接受受精/胞浆内精子注射治疗的子宫内膜异位症和非子宫内膜异位症患者中收集 CCs 和 MGCs。通过液相色谱-串联质谱 (LC-MS/MS) 测量 CCs 和 MGCs 的代谢组学,然后通过定量聚合酶链反应进一步确认参与代谢结果的基因。LC-MS/MS 分析显示,在 CCs 和 MGCs 中,组间有 24 种代谢物和 71 种代谢物存在差异。其中,在子宫内膜异位症的 CCs 中,有 5 种代谢物上调,19 种代谢物下调,而在子宫内膜异位症的 MGCs 中,有 3 种代谢物上调,68 种代谢物下调。与鞘脂代谢相关的代谢物,包括棕榈酸 (PA) 和二十二碳六烯酸,仅在子宫内膜异位症的 CCs 中显著增加,而鞘氨醇和 PA 在子宫内膜异位症的 MGCs 中与 CCs 和无子宫内膜异位症的 MGCs 相比显著下调。根据 FASN、BECN1 和 LAMP 蛋白表达,涉及神经酰胺合成 (CERS1、SPTL1 和 SMPD1) 和自噬 (BECN1、LAMP 和 PC3) 的基因表达在子宫内膜异位症的 CCs 中明显更高。然而,在子宫内膜异位症的 MGCs 中,涉及神经酰胺合成 (SPHK1、ASAH1 和 SGPP1) 和自噬 (BECN1、LAMP 和 PC3) 的基因表达明显较低,而 CERS1 和 UGCG 表达增加。与无子宫内膜异位症的患者相比,子宫内膜异位症的 CCs 和 MGCs 中的鞘脂代谢物存在差异。这些差异似乎参与了卵母细胞前颗粒细胞自噬性细胞死亡的调节。